marijuana stocks news

Form 8-K for VAPOR CORP.


14-Apr-2015

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.On April 14, 2015, Jeffrey Holman, the Chairman of the Board and Chief Executive Officer of Vapor Corp. (the “Company”) issued a shareholder update letter to the Company’s shareholders. A copy of the letter is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

The information furnished on this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

Exhibit No. Exhibit

99.1 Shareholder Update Letter dated April 14, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) Announces Positive Topline Results from KOMFORT Phase 2 Trial

Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of…

Leafbuyer Technologies, Inc. (LBUY) Signs Deal with Leading Colorado Dispensary Chain

Leafbuyer Technologies Signs Deal with Leading Colorado Dispensary Chain Leafbuyer Technologies, Inc. (LBUY)…

Curaleaf Holdings, Inc. (CURLF) Celebrates Nationwide Launch of New Mobile App

Curaleaf Celebrates Nationwide Launch of New Mobile App Curaleaf Holdings, Inc. (CSE:…

 InMed Pharmaceuticals Inc. (IMLFF) PCT Patent Application for Neuroprotection in Glaucoma

InMed Files PCT Patent Application for Neuroprotection in Glaucoma  InMed Pharmaceuticals Inc. (“InMed”…